Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

One of Australia's most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

子宫内膜癌（Endometrial Cancer, EC）是发达国家最常见的妇科恶性肿瘤，其分子特征和免疫微环境的复杂性一直是研究热点。2022年《Journal for ImmunoTherapy of Cancer》上《Biomarkers of ...

PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society ...

A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...

Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...

The following is a summary of “Facilitators and Barriers to Acceptability of a Biopsy-First Approach in the Diagnostic ...

AUSTIN, TX & PHILADELPHIA, PA — Faeth Therapeutics and The GOG Foundation, Inc. have announced a significant milestone in the ...

In patients with advanced or recurrent endometrial cancer (EC) with previous exposure to carboplatin and paclitaxel (PT), ...

H.C. Wainwright says that competitor data demonstrate impressive ORR in endometrial cancer, opening a potential opportunity for NetCure’s ...